Catalyst Event
Alnylam Pharmaceuticals Inc (ALNY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
3/24/2026, 12:00:00 AM
Alnylam will host an investor webinar on March 24, 2026, to discuss progress and growth of its flagship TTR franchise, marking the one-year anniversary of the AMVUTTRA approval for ATTR-CM, scheduled.
Korean Translation
2026년 3월 24일, AMVUTTRA의 ATTR-CM 치료제 승인 1주년을 기념하여 주력 TTR 프랜차이즈의 진행 상황 및 성장에 대해 논의하는 투자자 웨비나 개최 예정됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's earnings release for Q1 FY2027 is scheduled. A medium impact is estimated as earnings releases are key volatility drivers for retail stocks, expected.
5/21/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK 2026 Annual Meeting of Shareholders on May 20, 2026, scheduled.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM